"...is pleased to announce that in preclinical research, it's lead drug formulation, Rutherrin® was able to repurpose non-cancer drugs for cancer therapy."
Basically: non cancer drug A + non cancer drug B = cancer drug C
"...is pleased to announce that in preclinical research, it's lead drug formulation, Rutherrin® was able to repurpose non-cancer drugs for cancer therapy."
Basically: non cancer drug A + non cancer drug B = cancer drug C
There seem to be no end of things that can kill cancer cells provided they can be attached to same. Aye, matey, that's the snag especially with CTC PCa, dormant PCa, et al.
Love it maxone, they are getting closer to nailing this thing to a science. so many work now for different cancer cells, they just have to b able to figure out how to fine tune it to each cancer…!
repurposing these drugs are hands down the best approach, their efficiency is the key to battle the timeline and seem to be easily studied n very effective instead of pushing for these new highly expensive drugs that take ten years to get approved… and most of the time don’t work for long anyways…